Prostate Cancer - Vs morality. Science

Prostate Cancer - Vs morality. Science

 

with generalized as prostate cancer and other diseases, there is concern that eventually arise about treatments and tests for these diseases. Because these diseases are so prevalent in developed countries, diseases like cancer and diabetes are widely studied by research institutions around the world with the hope that there will be better treatments and rapid tests to determine if a person has the disease or not. However, by developing these treatments, preventive measures and genetic testing, people fall into the problem of what is moral. For diseases such as prostate cancer, morality is about to be sent to the wayside in an effort for people at high risk for the gene test for prostate cancer, long before they reach the age prostate cancer inside their bodies sprout. Perhaps the biggest debate on the morality of prostate cancer is whether scientists should develop tests for early detection of the disease in high-risk patients. Due to the high genetic correlation between those affected by prostate cancer and the likelihood that their children get the disease when they are older, a genetic test would be an excellent way to help people realize if they have prostate cancer in the future or not. Unfortunately for technologies that may ultimately exhibit for prostate cancer, morality soon enters the debate. If people find out when they are young they will have a high risk of prostate cancer at sixty years of age or younger, may have an experience a bit traumatic grow and feel that they will die in his sixties - especially if no cure for prostate cancer at the time. They would also have difficulty finding health insurance - as any self-respecting insurance company will want to ensure that a person will get an expensive sixty years old disease. There are two major concerns in terms of prostate morality.On the opposite side of the argument cancer, however, the people who say that the moral of prostate cancer should take a back seat to scientific advances will proclaim the benefits of testing Genetic early. People should be aware of the status of their health. If more people were to receive blood tests to determine if they are at risk for prostate cancer, they could go get more prostate exams which in turn lowers the death rate from prostate cancer. After all, it is very difficult for those who support the moral of prostate cancer to argue against people less dying.The whole battle between prostate cancer, morality and science needed to help cure certainly become in a heated debate in the future. Ultimately, the outcome will determine how well we handle other emerging diseases and whether we will do everything necessary to combat